today announced that Clara Curiel-Lewandrowski, MD, of the University of
Arizona Cancer Center is the 2018 Arizona Bioscience Researcher of the
Year. Dr. Curiel will be honored by Arizona’s bioscience and business
communities for her leadership and her work on both the treatment and
prevention of skin cancers at the AZBio Awards on October 3, 2018, at
the Phoenix Convention Center.
Dr. Curiel is a professor and vice chair of dermatology for the
University of Arizona College of Medicine – Tucson. She holds joint
roles as the director of the Multidisciplinary Cutaneous Oncology
Program and the clinical director for the University of Arizona Cancer
Center’s Skin Cancer Institute (SCI).
Prevention and early detection are essential in the fight against skin
cancers, but when they occur, we rely on Arizona’s leading researchers
The SCI unites the UA Cancer Center’s many skin cancer prevention
endeavors, bringing together innovative research, clinical care,
education and community outreach.
Since joining the UA Cancer Center in 2005, Dr. Curiel has impressed her
colleagues with her immense talent, tireless work ethic and overwhelming
motivation to fight skin cancer.
“Throughout her career, Dr. Curiel has provided exceptional and
compassionate care to patients, translated basic science into innovative
clinical applications, led groundbreaking clinical trials and invented
several technologies,” shared David Alberts, MD, founding director of
the SCI. “Dr. Curiel’s career trajectory has always been remarkable, and
we expect her to continue to reach new heights. In my more than 45 years
in academic medicine, she is one of the most brilliant investigators
with whom I have had the pleasure to work.”
Dr. Curiel’s research interests are in photobiology, early skin cancer
detection, biomarker development and primary prevention. She has taken
the initiative to address important clinical gaps in the skin cancer
prevention field through the innovative design and effective execution
of clinical studies.
“Dr. Curiel’s investigations into biomarkers for early skin cancer are
essential for finding better methods for identifying those at risk for
malignancy,” said Andrew Kraft, MD, director of the UA Cancer Center.
“She is interested in combining relevant biomarker assessment with novel
noninvasive monitoring tools, which is empowering dermatologists to
harness cutting-edge technology to better serve patients.”
Dr. Curiel has published more than 80 peer-reviewed articles and has
five patent applications. At the University of Arizona, she has trained
more than 35 graduate and postdoctoral students. She has served as the
principal investigator of 17 clinical trials, with the vast majority
being investigator-initiated studies as part of the UA NCI/DCP Cancer
Chemoprevention Consortium Agreement, P01 Skin Cancer Prevention studies
and sponsored studies.
“Dr. Curiel has a deep commitment to bring every Arizonan access to skin
cancer prevention, early detection and treatment at every stage of
disease,” said Monica Kraft, MD, chair of the Department of Medicine.
“She is a passionate clinician and investigator, and is also an engaged
Dr. Curiel is also the sponsor for novel IND indications for approved
drugs in the skin cancer field.
“Dr. Curiel’s work is an excellent example of the value created through
the combination of scientific and clinical research,” said Joan
Koerber-Walker, president and CEO of AZBio. “Incidences of skin cancer
are on the rise. This makes the work Dr. Curiel is doing for both cancer
prevention and cancer treatment an important part of the fight against
For her commitment to pushing the frontiers of science for the
betterment of people in Arizona and around the world, Clara
Curiel-Lewandrowski, MD, is the 2018 Arizona Bioscience Researcher of
A key component of Arizona
Bioscience Week, The AZBio Awards & Life Science Fiesta brings
together Arizona’s life science and leadership community with visitors
from around the country to celebrate life-science innovation and
innovators. The AZBio
Awards takes place on the evening of October 3, 2018, at the Phoenix
Convention Center. Highlights of the evening will include honoring
Daniel D. Von Hoff, MD, with the AZBio Pioneer Award for Lifetime
Achievement and a celebration of the achievements of leading
researchers, educators and innovator companies. The Life Science Fiesta
following the award ceremony features a Student Discovery Zone that
showcases the work of 50 students from Arizona high schools, community
colleges and universities along with exhibits featuring Arizona
companies and patient advocacy organizations. The AZBio Awards & Life
Science Fiesta is presented by AZBio and the Arizona
The White Hat Life Science Investor Conference (White
Hat 2018) brings together the next generation of biotech and health
care pioneers from across the Rocky Mountain Southwest Region with
investors locally, nationally and internationally. Held at the Phoenix
Convention Center on October 4, 2018, White Hat 2018 is a collaboration
between bioscience industry associations across the region. The
conference showcases opportunities for investment into privately held
companies in the areas of diagnostics, therapeutics, medical devices and
health information technology. Thirty-two companies have been
competitively selected by a committee of experienced life science
investors to present at White Hat 2018. Companies that presented at
White Hat in 2014 and 2016 have gone on to receive almost $200 million
in investment from private and corporate investors.
For more information on Arizona Bioscience Week, visit www.AZBio.org/AZBW2018.
For more information on the 2018 AZBio Awards, visit www.AZBioAwards.com.
For more information about White Hat 2018, visit www.WhiteHatInvestors.com.
About Skin Cancers
Skin cancer is the most common form of cancer in the United States. It
is estimated that more than 5 million new cases are diagnosed each
year — more than all other cancers combined.
One in five Americans will get skin cancer in his or her lifetime with
potential significant consequences in morbidity and mortality.
Detecting skin cancer before it becomes a serious problem is a team
effort. Individuals should discuss with their primary provider their
risk for developing skin cancer and perform skin cancer
self-examinations at home. When patients have multiple risk factors, a
more detailed assessment by a dermatologist might be indicated.
The best way to prevent skin cancer is to be sun smart, especially
here in Arizona. This is one of the very few cancers you can prevent
in your lifetime. When you are out in the sun, cover up, use sunscreen
and reapply it frequently.
For 15 years, the Arizona Bioindustry Association (AZBio) has supported
life science innovation and life science innovators in Arizona. A key
component in Arizona’s life science ecosystem, AZBio is the only
statewide organization exclusively focused on Arizona’s bioscience
industry. AZBio membership includes patient advocacy organizations, life
science innovators, educators, health care partners and leading business
organizations. AZBio is the statewide affiliate of the Biotechnology
Innovation Organization (BIO) and works in partnership with AdvaMed,
MDMA and PhRMA to advance innovation and to ensure that the value
delivered from life-changing and life-saving innovation benefits people
in Arizona and around the world.
For more information, visit www.AZBio.org
AZBio Media Contact:
Joan Koerber-Walker, Arizona
available upon request.